[{"Assets_0_Q3_USD":159691000.0,"CommonStockSharesOutstanding_0_Q3_shares":31142643.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-20474000.0,"NetIncomeLoss_1_Q3_USD":-6885000.0,"NetIncomeLoss_3_Q3_USD":-18439000.0,"StockholdersEquity_0_Q3_USD":111392000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":31134009.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":13614087.0,"Ticker":"PSNL","CIK":"1527753","name":"PERSONALIS, INC.","OfficialName":"Personalis Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"307257592.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20191113"}]